Latikafusp represents a distinct therapeutic approach for treating specific cancers, particularly cases involving aberrant ALK proteins. This drug functions as an blocker of shortened ALK structures, demonstrating https://mediajx.com/story27765407/latikafusp-a-groundbreaking-therapeutic-method